Abacus Medicine

📍 København, Denmark🗓 Founded 2004👥 709 employees💰 Last funded May 2017
Pharmaceutical Manufacturing🌐 abacusmedicinegroup.com
Website LinkedIn
Even the best medicine in the world won’t work if it never reaches the patient, and insufficient access is a large and growing problem. The Abacus Medicine Group offers a range of different solutions and services that provide better access to life-critical medicine at affordable prices to millions of patients across the world. Our business purpose holds a substantial positive impact on healthcare systems and society and is something were proud of. The company was founded in 2004 by CEO Flemming Wagner and Medical Director John Wagner and has experienced significant growth ever since. Today, we are more than 1,300 colleagues moving healthcare in Europe and beyond. The Abacus Medicine Group is among the 100 largest Danish companies. The Group operates as four brands: Abacus Medicine, Pluripharm, Abacus Medicine Pharma Services and Originalis. Learn more about the Abacus Medicine Group on our website below.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Abacus Medicine?
Abacus Medicine has 1 investors on record on gritt.io.
When did Abacus Medicine last raise funding?
The most recent investment in Abacus Medicine recorded on gritt.io was in May 2017.
When was Abacus Medicine founded?
Abacus Medicine was founded in 2004.
What industry is Abacus Medicine in?
Abacus Medicine operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Abacus Medicine based?
Abacus Medicine is headquartered in København, Denmark.